Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Glioma · CNS Tumor, Adult · CNS Tumor, Childhood

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institut de Cancérologie de l'Ouest, Angers, France
Contact: Study coordinator (Pierre KUBICEK, MD) · pierre.kubicek@ico.unicancer.fr · +33241352700
Contact: Principal Investigator (Pierre KUBICEK)
Hôpital Universitaire d'Angers, Angers, France
Contact: Study coordinator (Claire BRISSET, MD) · claire.brisset@chu-angers.fr · +33241353863
Contact: Principal Investigator (Claire BRISSET)
CHU de Bordeaux, Bordeaux, France
Contact: Study coordinator (Céline ICHER, MD) · celine.icher@chu-bordeaux.fr · +33557820448
Contact: Principal Investigator (Céline ICHER)
Hôpital Saint-André, Bordeaux, France
Contact: Study coordinator (Mathieu LARROQUETTE) · mathieu.larroquette@chu-bordeaux.fr · +33556795808
Contact: Principal Investigator (Mathieu LARROQUETTE)
Hôpital Neurologique Pierre Wertheimer, Bron, France
Contact: Study coordinator (François DUCRAY, MD) · francois.ducray@chu-lyon.fr · +33472681321
Contact: Principal Investigator (François DUCRAY)
Centre Oscar Lambret, Lille, France
Contact: Study coordinator (François SEVRIN, MD) · f-sevrin@o-lambret.fr · +33320295959
Contact: Principal Investigator (François SEVRIN)
Centre Léon Bérard, Lyon, France
Contact: Study coordinator (Pierre LEBLOND, MD, PhD) · pierre.leblond@ihope.fr · +33469166550
Contact: Study coordinator (Aurélien MAUREILLE, MD) · aurelien.maureille@lyon.unicancer.fr · +33469166645
Contact: Principal Investigator (Pierre LEBLOND)
Contact: Principal Investigator (Aurélien MAUREILLE)
Hôpital de la Timone - service adulte, Marseille, France
Contact: Study coordinator (Emeline TABOURET, MD) · emeline.tabouret@ap-hm.fr · +33491384644
Contact: Principal Investigator (Emeline TABOURET)
Hôpital de la Timone - service pédiatrie, Marseille, France
Contact: Study coordinator (Nicolas ANDRE, MD) · nicolas.andre@ap-hm.fr · +33491386821
Contact: Principal Investigator (Nicolas ANDRE)
Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France
Contact: Study coordinator (Medhi TOUAT, MD) · mehdi.touat@aphp.fr · +33142160385
Contact: Principal Investigator (Mehdi TOUAT)
IUCT - Claudius Regaud, Toulouse, France
Contact: Study coordinator (Delphine LARRIEU-CIRON, MD) · larrieuciron.delphine@iuct-oncopole.fr · +33531155674
Contact: Principal Investigator (Delphine LARRIEU-CIRON)
Institut Gustave Roussy, Villejuif, France
Contact: Study coordinator (Jacques GRILL, MD) · jacques.grill@gustaveroussy.fr · +33142116209
Contact: Principal Investigator (Jacques GRILL)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors

CNS Tumor · Artificial Intelligence (AI) · Glioma

Abroad (travel likely)Recruiting

Mumbai, India

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Low-Grade Glioma · Recurrent Low-Grade Glioma · Progressive Low-Grade Glioma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Memphis, United States

Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

Glioblastoma · WHO Grade II Glioma · WHO Grade III Glioma

Abroad (travel likely)Recruiting

Houston, United States

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

Recurrent World Health Organization (WHO) Grade II Glioma · Low-grade Glioma · High Grade Glioma

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · Los Angeles, United States